AAAAAA

   
Results: 1-14 |
Results: 14

Authors: Kolenko, VM Uzzo, RG Dulin, N Hauzman, E Bukowski, R Finke, JH
Citation: Vm. Kolenko et al., Mechanism of apoptosis induced by zinc deficiency in peripheral blood T lymphocytes, APOPTOSIS, 6(6), 2001, pp. 419-429

Authors: Finke, JH Rayman, P George, R Tannenbaum, CS Kolenko, V Uzzo, R Novick, AC Bukowski, RM
Citation: Jh. Finke et al., Tumor-induced sensitivity to apoptosis in T cells from patients with renalcell carcinoma: Role of nuclear factor-kappa B suppression, CLIN CANC R, 7(3), 2001, pp. 940S-946S

Authors: Uzzo, RG Kolenko, V Froelich, CJ Tannenbaum, C Molto, L Novick, AC Bander, NH Bukowski, R Finke, JH
Citation: Rg. Uzzo et al., The T cell death knell: Immune-mediated tumor death in renal cell carcinoma, CLIN CANC R, 7(10), 2001, pp. 3276-3281

Authors: Cohen, PA Peng, LM Kjaergaard, J Plautz, GE Finke, JH Koski, GK Czerniecki, BJ Shu, SY
Citation: Pa. Cohen et al., T-cell adoptive therapy of tumors: Mechanisms of improved therapeutic performance, CR R IMMUN, 21(1-3), 2001, pp. 215-248

Authors: Uzzo, RG Dulin, N Bloom, T Bukowski, R Finke, JH Kolenko, V
Citation: Rg. Uzzo et al., Inhibition of NF kappa B induces caspase-independent cell death in human Tlymphocytes, BIOC BIOP R, 287(4), 2001, pp. 895-899

Authors: Uzzo, RG Kolenko, V Novick, AC Finke, JH
Citation: Rg. Uzzo et al., Assessment of T-cell immune dysfunction in patients with renal cell carcinoma, METH MOL M, 53, 2001, pp. 361-376

Authors: Kolenko, VM Uzzo, RG Bukowski, R Finke, JH
Citation: Vm. Kolenko et al., Caspase-dependent and -independent death pathways in cancer therapy, APOPTOSIS, 5(1), 2000, pp. 17-20

Authors: Rayman, P Uzzo, RG Kolenko, V Bloom, T Cathcart, MK Molto, L Novick, AC Bukowski, RM Hamilton, T Finke, JH
Citation: P. Rayman et al., Tumor-induced dysfunction in interleukin-2 production and interleukin-2 receptor signaling: A mechanism of immune escape, CA J SCI AM, 6, 2000, pp. S81-S87

Authors: Finke, JH Kierstead, LS Ranieri, E Storkus, WJ
Citation: Jh. Finke et al., Immunologic response to renal cell carcinoma, CUR CLIN ON, 4, 2000, pp. 39-62

Authors: Uzzo, RG Clark, PE Rayman, P Bloom, T Rybicki, L Novick, AC Bukowski, RM Finke, JH
Citation: Rg. Uzzo et al., Alterations in NF kappa B activation in T lymphocytes of patients with renal cell carcinoma, J NAT CANC, 91(8), 1999, pp. 718-721

Authors: Ulchaker, J Panuto, J Rayman, P Novick, A Elson, P Tubbs, R Finke, JH Bukowski, RM
Citation: J. Ulchaker et al., Interferon-gamma production by T lymphocytes from renal cell carcinoma patients: Evidence of impaired secretion in response to interleukin-12, J IMMUNOTH, 22(1), 1999, pp. 71-79

Authors: Uzzo, RG Rayman, P Kolenko, V Clark, PE Bloom, T Ward, AM Molto, L Tannenbaum, C Worford, LJ Bukowski, R Tubbs, R Hsi, ED Bander, NH Novick, AC Finke, JH
Citation: Rg. Uzzo et al., Mechanisms of apoptosis in T cells from patients with renal cell carcinoma, CLIN CANC R, 5(5), 1999, pp. 1219-1229

Authors: Uzzo, RG Rayman, P Kolenko, V Clark, PE Cathcart, MK Bloom, T Novick, AC Bukowski, RM Hamilton, T Finke, JH
Citation: Rg. Uzzo et al., Renal cell carcinoma-derived gangliosides suppress nuclear factor-kappa B activation in T cells, J CLIN INV, 104(6), 1999, pp. 769-776

Authors: Kolenko, V Uzzo, RG Bukowski, R Bander, NH Novick, AC Hsi, ED Finke, JH
Citation: V. Kolenko et al., Dead or dying: Necrosis versus apoptosis in caspase-deficient human renal cell carcinoma, CANCER RES, 59(12), 1999, pp. 2838-2842
Risultati: 1-14 |